Literature DB >> 14569337

Usefulness of corneal esthesiometry for screening diabetic retinopathy.

Lênio Souza Alvarenga1, Elisabeth Nogueira Martins, Gustavo Teixeira Grottone, Paulo Henrique Avila Morales, Augusto Paranhos, Denise de Freitas, Marinho Jorge Scarpi.   

Abstract

OBJECTIVE: To assess the usefulness of corneal esthesiometry for screening diabetic retinopathy.
METHODS: A cross-sectional study was carried out comprising 575 patients attending a diabetic retinopathy-screening program in the city of São Paulo. Corneal esthesiometry was assessed with the Cochet-Bonnet esthesiometer. The presence of diabetic retinopathy was detected with indirect fundoscopy. The validity of corneal esthesiometry in identifying diabetic retinopathy was evaluated by the Receiver Operating Characteristic (ROC) curve.
RESULTS: Sensitivity and specificity analyses of the corneal esthesiometry for detecting the stages of diabetic retinopathy using different cut-offs showed values less than 80%. The best indices (72.2% sensitivity and 57.4% specificity) were obtained for the identification of patients with proliferative diabetic retinopathy.
CONCLUSIONS: In the study series, corneal esthesiometry was not a good indicator of diabetic retinopathy.

Entities:  

Mesh:

Year:  2003        PMID: 14569337     DOI: 10.1590/s0034-89102003000500010

Source DB:  PubMed          Journal:  Rev Saude Publica        ISSN: 0034-8910            Impact factor:   2.106


  2 in total

1.  Conjunctival and corneal sensitivity in patients under topical antiglaucoma treatment.

Authors:  Lorena Romero-Díaz de León; Jorge-Emmanuel Morales-León; Jasbeth Ledesma-Gil; Alejandro Navas
Journal:  Int Ophthalmol       Date:  2015-08-14       Impact factor: 2.031

2.  Tear biomarkers and corneal sensitivity as an indicator of neuropathy in type 2 diabetes.

Authors:  Meera F Iyengar; Luis F Soto; David Requena; Andrea O Ruiz-Alejos; Yvonne Huaylinos; Ricardo Velasquez; Antonio Bernabe-Ortiz; Robert H Gilman
Journal:  Diabetes Res Clin Pract       Date:  2020-04-10       Impact factor: 5.602

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.